Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

View all journals
Search
Log in

nature
search

Search

Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

Scientific Reports (4)
Pediatric Research (1)
Nature Communications (1)
npj Breast Cancer (1)

Choose more journals

Article type Check one or more article types to show results from those article types only.

Research (7)

Subject Check one or more subjects to show results from those subjects only.

Biomarkers
Cancer
Computational biology and bioinformatics
Genetics
Oncology

Date Choose a date option to show results from those dates only.

Today
Last 7 days
Last 30 days
Last 12 months
Last 2 years
Last 5 years

Custom date range

Clear all filters

Sort by:

Relevance

Date published (new to old)

Date published (old to new)

Showing 1–7 of 7 results

Advanced filters: Author: Michelle B. Nadler Clear advanced filters

Influence of Competing Risks on Estimates of Recurrence Risk and Breast Cancer-specific Mortality in Analyses of the Early Breast Cancer Trialists Collaborative Group

Ramy R. Saleh
Michelle B. Nadler
Eitan Amir
ResearchOpen Access05 Mar 2020
Scientific Reports

Volume: 10, P: 1-7
DYSMORPHIC SYNDROME, SPHEROCYTOSIS AND PARTIAL DELETION OF THE SHORT ARM OF CHROMOSOME 8

Robert R Chilcote
Barbara Jones
Eugene Pergament
Research01 Apr 1984
Pediatric Research

Volume: 18, P: 220
Longitudinal evaluation of circulating tumor DNA in patients undergoing neoadjuvant therapy for early breast cancer using a tumor-informed assay

Tumour-informed ctDNA is a sensitive potential biomarker for treatment response in breast cancer. Here, the authors use longitudinal sampling to predict disease recurrence during neoadjuvant and adjuvant treatment.

Mitchell J. Elliott
Philippe Echelard
David W. Cescon
ResearchOpen Access21 Feb 2025
Nature Communications

Volume: 16, P: 1-13
A retrospective analysis of changes in distant and breast cancer related disease-free survival events in adjuvant breast cancer trials over time

Brooke E. Wilson
Alexandra Desnoyers
Eitan Amir
ResearchOpen Access15 Apr 2022
Scientific Reports

Volume: 12, P: 1-8
Comparative overall survival of CDK4/6 inhibitors in combination with endocrine therapy in advanced breast cancer

Coralea Kappel
Mitchell J. Elliott
Eitan Amir
ResearchOpen Access07 Feb 2024
Scientific Reports

Volume: 14, P: 1-7
Magnitude of effect and sample size justification in trials supporting anti-cancer drug approval by the US Food and Drug Administration

Michelle B. Nadler
Brooke E. Wilson
Eitan Amir
ResearchOpen Access03 Jan 2024
Scientific Reports

Volume: 14, P: 1-9
Personalized ctDNA monitoring in metastatic HR+/HER2− breast cancer patients during endocrine and CDK4/6 inhibitor therapy

Jesús Fuentes-Antrás
Mitchell J. Elliott
David W. Cescon
ResearchOpen Access19 Jul 2025
npj Breast Cancer

Volume: 11, P: 1-12